Rankings
▼
Calendar
EWTX Q4 2020 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.31
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$190,000
Balance Sheet
Total Assets
$131M
Total Liabilities
$165M
Stockholders' Equity
-$33M
Cash & Equivalents
$105M
← FY 2020
All Quarters
Q1 2021 →
